1. Home
  2. ABVC vs BMRA Comparison

ABVC vs BMRA Comparison

Compare ABVC & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • BMRA
  • Stock Information
  • Founded
  • ABVC 2015
  • BMRA 1971
  • Country
  • ABVC United States
  • BMRA United States
  • Employees
  • ABVC N/A
  • BMRA N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ABVC Health Care
  • BMRA Health Care
  • Exchange
  • ABVC Nasdaq
  • BMRA Nasdaq
  • Market Cap
  • ABVC 6.5M
  • BMRA 7.4M
  • IPO Year
  • ABVC N/A
  • BMRA N/A
  • Fundamental
  • Price
  • ABVC $0.50
  • BMRA $0.30
  • Analyst Decision
  • ABVC
  • BMRA
  • Analyst Count
  • ABVC 0
  • BMRA 0
  • Target Price
  • ABVC N/A
  • BMRA N/A
  • AVG Volume (30 Days)
  • ABVC 361.4K
  • BMRA 2.3M
  • Earning Date
  • ABVC 11-14-2024
  • BMRA 01-14-2025
  • Dividend Yield
  • ABVC N/A
  • BMRA N/A
  • EPS Growth
  • ABVC N/A
  • BMRA N/A
  • EPS
  • ABVC N/A
  • BMRA N/A
  • Revenue
  • ABVC $509,788.00
  • BMRA $5,509,000.00
  • Revenue This Year
  • ABVC N/A
  • BMRA N/A
  • Revenue Next Year
  • ABVC N/A
  • BMRA N/A
  • P/E Ratio
  • ABVC N/A
  • BMRA N/A
  • Revenue Growth
  • ABVC N/A
  • BMRA 1.74
  • 52 Week Low
  • ABVC $0.41
  • BMRA $0.24
  • 52 Week High
  • ABVC $2.45
  • BMRA $1.51
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 36.66
  • BMRA 47.80
  • Support Level
  • ABVC $0.47
  • BMRA $0.27
  • Resistance Level
  • ABVC $0.52
  • BMRA $0.48
  • Average True Range (ATR)
  • ABVC 0.04
  • BMRA 0.04
  • MACD
  • ABVC -0.00
  • BMRA -0.00
  • Stochastic Oscillator
  • ABVC 25.56
  • BMRA 23.86

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Share on Social Networks: